MET (MetLife) Stock Analysis - Analyst Ratings

MetLife (MET) is a publicly traded Financial Services sector company. As of May 20, 2026, MET trades at $82.01 with a market cap of $52.38B and a P/E ratio of 15.88. MET moved +1.77% today. Year to date, MET is +0.90%; over the trailing twelve months it is +2.71%. Its 52-week range spans $65.21 to $89.05. Analyst consensus is strong buy with an average price target of $93.20. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MET?

11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $93.20.

MET Key Metrics

Key financial metrics for MET
MetricValue
Price$82.01
Market Cap$52.38B
P/E Ratio15.88
EPS$5.20
Dividend Yield0.59%
52-Week High$89.05
52-Week Low$65.21
Volume2.09M
Avg Volume0
Revenue (TTM)$77.59B
Net Income$3.62B
Gross Margin0.00%

MET Analyst Consensus

11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.20.

Latest MET News

Common questions about MET

What do analysts rate MET?
11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $93.20.
Does Rallies show MET price targets?
Yes. Rallies tracks MET analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MET research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MET. It does not provide personalized investment advice.
MET

MetLife